Platelet-active drugs: the relationships among dose, effectiveness, and side effects.

By C. Patrono, B. Coller, J. Dalen, Valentín Fuster, M. Gent, L. Harker, J. Hirsh, G. Roth. Chest, 2004

1,002 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Internal Medicine, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/4d782f983ef925a398f7063e429aa01fc6e3c17e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Alexander Zarbock
2. R. Polanowska-Grabowska
3. Klaus Ley

Citations in the corpus

• Platelet-neutrophil-interactions: linking hemostasis and inflammation. (2007, background): “Oral long-term treatment with GIIb/IIIa inhibitors is not more effective than aspirin or, when combined with aspirin, is not superior to aspirin plus placebo.(139,140) Novel therapeutic approaches targeting GPVI and GPIba are under experimental development.”